SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies, announced the grand opening of its state-of-the-art TIL manufacturing...
Read More Details
Finally We wish PressBee provided you with enough information of ( Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production )
Also on site :
- Ministry of Economy Establishes the Syrian-Canadian Business Council
- Today’s NYT ‘Strands’ Hints, Spangram and Answers for Friday, July 4
- Beloved ‘60s Icon, 75, Dazzles London Event in Chic Pink Blazer and High-Top Sneakers